| 수집원 | 발생값 ↑ | 관측 가능 시각 | 법인 | 회사명 | 사업연도 | 기간 | 연결구분 | 재무제표 | 계정명 | 표준 지표 | 금액 | 기준일 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | OFS | IS | 당기순이익(손실) | net_income | 3336.2억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:02 | — | POSCO홀딩스 | 2,025 | H1 | CFS | BS | 이익잉여금 | retained_earnings | 53.3조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,025 | H1 | OFS | BS | 유동부채 | current_liabilities | 19.5조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:02 | — | POSCO홀딩스 | 2,025 | H1 | OFS | BS | 부채총계 | total_liabilities | 3.6조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,025 | H1 | OFS | BS | 자산총계 | total_assets | 96.3조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:17 | — | SK텔레콤 | 2,025 | H1 | CFS | BS | 자본금 | capital_stock | 304.9억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | OFS | BS | 자본총계 | total_equity | 9.9조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | OFS | IS | 총포괄손익 | comprehensive_income | 3331.3억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | OFS | BS | 비유동부채 | non_current_liabilities | 1.3조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,025 | H1 | OFS | BS | 비유동자산 | non_current_assets | 73.3조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | OFS | BS | 부채총계 | total_liabilities | 3.6조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,025 | H1 | OFS | BS | 유동자산 | current_assets | 22.9조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | OFS | BS | 유동부채 | current_liabilities | 2.2조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | OFS | BS | 자본금 | capital_stock | 1779.3억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | OFS | BS | 유동자산 | current_assets | 3.8조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | OFS | BS | 비유동자산 | non_current_assets | 9.7조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,025 | H1 | CFS | IS | 총포괄손익 | comprehensive_income | 5960.2억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,025 | H1 | CFS | IS | 당기순이익(손실) | net_income | 3.2조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | OFS | BS | 자산총계 | total_assets | 13.5조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | OFS | BS | 이익잉여금 | retained_earnings | 4.1조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | CFS | IS | 매출액 | revenue | 1.2조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,025 | H1 | CFS | IS | 법인세차감전 순이익 | pretax_income | 4.3조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | CFS | IS | 영업이익 | operating_income | 4755.9억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,025 | H1 | CFS | IS | 영업이익 | operating_income | 3.6조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | CFS | BS | 자본총계 | total_equity | 11.6조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | CFS | IS | 법인세차감전 순이익 | pretax_income | 4089억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | CFS | BS | 부채총계 | total_liabilities | 6.1조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,025 | H1 | CFS | IS | 매출액 | revenue | 48.2조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | CFS | BS | 자본금 | capital_stock | 1779.3억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,025 | H1 | CFS | BS | 자본총계 | total_equity | 121.5조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:54 | — | 삼성전자 | 2,025 | H1 | CFS | BS | 비유동부채 | non_current_liabilities | 20.9조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | CFS | BS | 이익잉여금 | retained_earnings | 5.7조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | CFS | IS | 당기순이익(손실) | net_income | 3243.8억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | CFS | BS | 비유동자산 | non_current_assets | 12조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,025 | H1 | CFS | BS | 이익잉여금 | retained_earnings | 99.2조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | CFS | BS | 자산총계 | total_assets | 17.7조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,025 | H1 | CFS | BS | 자본금 | capital_stock | 1.4조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | CFS | BS | 유동자산 | current_assets | 5.7조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | CFS | BS | 유동부채 | current_liabilities | 3.6조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:54 | — | 삼성전자 | 2,025 | H1 | CFS | BS | 유동부채 | current_liabilities | 84.4조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,025 | H1 | CFS | BS | 부채총계 | total_liabilities | 218.1조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,025 | H1 | CFS | BS | 비유동부채 | non_current_liabilities | 136.8조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | CFS | BS | 비유동부채 | non_current_liabilities | 2.5조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | CFS | IS | 총포괄손익 | comprehensive_income | 3226.8억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:07 | — | LG에너지솔루션 | 2,025 | H1 | CFS | BS | 유동자산 | current_assets | 16.3조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,025 | H1 | CFS | BS | 유동부채 | current_liabilities | 81.3조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,025 | H1 | CFS | BS | 자산총계 | total_assets | 339.7조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,025 | H1 | CFS | BS | 비유동자산 | non_current_assets | 226조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,025 | H1 | CFS | BS | 유동자산 | current_assets | 113.6조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:57 | — | NAVER | 2,025 | H1 | OFS | IS | 총포괄손익 | comprehensive_income | 9514.3억원 | 2025-06-30 |